Sustained ocular drug delivery via innovative dosage forms
Celanese offers the innovative VitalDose® Platform, for targeted ocular delivery of small molecules, biologics, and RNA to treat conditions such as retinal diseases, glaucoma, and inflammation.
VitalDose® EVA provides controlled drug release through implants and inserts. Compared to traditional dose forms, the VitalDose® platform reduces treatment burden, addresses patient adherence issues, and improves bioavailability. We partner with you to enable innovative drug delivery of your API within your desired release profile.
Collaborate with experts from our Pharma Feasibility Lab to solve your drug delivery problems. We are equipped to design and fabricate functional API-loaded prototypes, characterize prototype morphology and API release, and provide technical transfer support.
With decades of experience in medical and pharmaceutical applications, our customers trust us to provide unrivaled service, world-class expertise, and quality that improves development, enhances manufacturability, and elevates patient care.
Brands: Celanese offers the innovative VitalDose® Platform, for targeted ocular delivery of small molecules, biologics, and RNA to treat conditions such as retinal diseases, glaucoma, and inflammation.